1. AHRO : Austin Health Research Online

Mathis Grossmann

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Mathis Grossmann
Full Name
Grossmann, Mathis
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Yeap, Bu B

Results 1-16 of 16 (Search time: 0.004 seconds).

Publication YearTitleAuthor(s)
121-Dec-2023Long-Term Outcomes of Testosterone Treatment in Men: A T4DM Post-Randomisation Observational Follow-Up Study.Handelsman, David J; Grossmann, Mathis ; Yeap, Bu B; Stuckey, Bronwyn Ga; Shankara-Narayana, Nandini; Conway, Ann J; Inder, Warrick J; McLachlan, Robert I; Allan, Carolyn; Jenkins, Alicia J; Jesudason, David; Bracken, Karen; Wittert, Gary A
21-Sep-2023Testosterone and type 2 diabetes prevention: translational lessons from the T4DM study.Wittert, Gary A; Grossmann, Mathis ; Yeap, Bu B; Handelsman, David J
310-Jul-2023Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial.Robledo, Kristy P; Marschner, Ian C; Handelsman, David J; Bracken, Karen; Stuckey, Bronwyn G A; Yeap, Bu B; Inder, Warrick; Grossmann, Mathis ; Jesudason, David; Allan, Carolyn A; Wittert, Gary
413-Jul-2021Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT.Ng Tang Fui, Mark ; Hoermann, Rudolf; Bracken, Karen; Handelsman, David J; Inder, Warrick J; Stuckey, Bronwyn G A; Yeap, Bu B; Ghasem-Zadeh, Ali ; Robledo, Kristy P; Jesudason, David; Zajac, Jeffrey D ; Wittert, Gary A; Grossmann, Mathis 
58-Mar-2021Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT.Ng Tang Fui, Mark ; Hoermann, Rudolf; Bracken, Karen; Handelsman, David J; Inder, Warrick J; Stuckey, Bronwyn G A; Yeap, Bu B; Ghasem-Zadeh, Ali ; McLachlan, Robert; Robledo, Kristy P; Jesudason, David; Zajac, Jeffrey D ; Wittert, Gary A; Grossmann, Mathis 
6Jan-2021Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.Wittert, Gary; Bracken, Karen; Robledo, Kristy P; Grossmann, Mathis ; Yeap, Bu B; Handelsman, David J; Stuckey, Bronwyn; Conway, Ann; Inder, Warrick; McLachlan, Robert; Allan, Carolyn; Jesudason, David; Ng Tang Fui, Mark ; Hague, Wendy; Jenkins, Alicia; Daniel, Mark; Gebski, Val; Keech, Anthony
7Dec-2019A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial.Bracken, Karen; Keech, Anthony; Hague, Wendy; Allan, Carolyn; Conway, Ann; Daniel, Mark; Gebski, Val; Grossmann, Mathis ; Handelsman, David J; Inder, Warrick J; Jenkins, Alicia; McLachlan, Robert; Robledo, Kristy P; Stuckey, Bronwyn; Yeap, Bu B; Wittert, Gary
819-Jun-2019Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies.Bracken, Karen; Hague, Wendy; Keech, Anthony; Conway, Ann; Handelsman, David J; Grossmann, Mathis ; Jesudason, David; Stuckey, Bronwyn; Yeap, Bu B; Inder, Warrick; Allan, Carolyn; McLachlan, Robert; Robledo, Kristy P; Wittert, Gary
930-Apr-2019Telephone Call Reminders Did Not Increase Screening Uptake More Than SMS Reminders: A Recruitment Study Within a TrialBracken, Karen; Keech, Anthony; Hague, Wendy; Kirby, Adrienne; Robledo, Kristy P; Allan, Carolyn; Conway, Ann; Daniel, Mark; Gebski, Val; Grossmann, Mathis ; Handelsman, David J; Inder, Warrick; Jenkins, Alicia; McLachlan, Robert; Stuckey, Bronwyn; Yeap, Bu B; Wittert, Gary
10Apr-2019Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomised controlled trial.Wittert, Gary; Atlantis, Evan; Allan, Carolyn; Bracken, Karen; Conway, Ann; Daniel, Mark; Gebski, Val; Grossmann, Mathis ; Hague, Wendy; Handelsman, David; Inder, Warrick; Jenkins, Alicia; Keech, Anthony; McLachlan, Rob; Robledo, Kristy; Stuckey, Bronwyn; Yeap, Bu B
11Aug-2018Testosterone treatment in older men: clinical implications and unresolved questions from the Testosterone Trials.Yeap, Bu B; Page, Stephanie T; Grossmann, Mathis 
12Oct-2017Effects of androgen deprivation therapy on telomere length.Cheung, Ada S ; Yeap, Bu B; Hoermann, Rudolf; Hui, Jennie; Beilby, John P; Grossmann, Mathis 
135-Sep-2016Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerationsYeap, Bu B; Grossmann, Mathis ; McLachlan, Robert I; Handelsman, David J; Wittert, Gary A; Conway, Ann J; Stuckey, Bronwyn GA; Lording, Douglas W; Allan, Carolyn A; Zajac, Jeffrey D ; Burger, Henry G
1415-Aug-2016Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapyYeap, Bu B; Grossmann, Mathis ; McLachlan, Robert I; Handelsman, David J; Wittert, Gary A; Conway, Ann J; Stuckey, Bronwyn GA; Lording, Douglas W; Allan, Carolyn A; Zajac, Jeffrey D ; Burger, Henry G
151-Jan-2015Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men.Yeap, Bu B; Alfonso, Helman; Chubb, S A Paul; Gauci, Richard; Byrnes, Elizabeth; Beilby, John P; Ebeling, Peter R; Handelsman, David J; Allan, Carolyn A; Grossmann, Mathis ; Norman, Paul E; Flicker, Leon
162015Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials.Grossmann, Mathis ; Hoermann, Rudolf; Wittert, Gary; Yeap, Bu B